研究方向: 抗病毒和抗痛风药物研究
学习工作经历(从大学开始): 2023.07-2025.07,复旦大学,化学流动站,博士后 2019.09 - 2023.06,延边大学,药学院,博士(复旦大学联合培养) 2015.09 - 2018.06,延边大学,药学院,硕士 2011.09 - 2015.06,延边大学,药学院,本科
代表性论文或专利: Li-min Zhao, et al. Structure-based design of novel heterocycle substituted ATDP analogs as non-nucleoside reverse transcriptase inhibitors with improved selectivity and solubility. Acta Pharmaceutica Sinica B 2023;13(12):4906-4917 Li-min Zhao, et al. Structure-directed expansion of biphenyl-pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with significantly improved potency and safety.Chinese Chemical Letters2023, 108261 Li-min Zhao, et al. Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailability. Eur J Med Chem 2022, 240, 114581 Kun Zhang1, Li-min Zhao1, et al. Rational structure-based design and optimization of next-generation biphenyl-piperidine-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Chinese Chemical Letters2025, 111283
获奖情况: 2023年分别获得上海市超级博士后和复旦大学超级博士后 学术任职:
|